Jean-Frederic Viret

CIK 1427569 · Chief Financial Officer · last filed 2026-02-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$96.2K

Companies

4

Total Filings

43

Lifetime Open-Market Net

-$2.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SGP Chief Financial Officer $18.44 $0 1 2026-02-09
NGM BIOPHARMACEUTICALS INC (NGM) Delisted Chief Financial Officer 0 $1.54 $0 $0 2 2024-04-08
CHRS Chief Financial Officer 68,697 $1.40 $96.2K -$2.85M 36 2021-02-03
ANESIVA, INC. (ANSV) Delisted VP and Chief Financial Officer 6,541 $0 2 2008-12-05

Recent Filings · Page 4 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-12-20 CHRS Mixed +667 -$48.7K EDGAR
2016-11-22 CHRS Mixed -$57.3K EDGAR
2016-10-25 CHRS Mixed -$66.8K EDGAR
2016-09-28 CHRS Mixed -$63.9K EDGAR
2016-07-08 CHRS Exer (M) +1,925 $26.0K EDGAR
2016-05-13 CHRS Grant (A) $0 EDGAR
2016-03-30 CHRS Exer (M) +400 $5.4K EDGAR
2015-04-03 CHRS Grant (A) $0 EDGAR
2014-11-12 CHRS Grant (A) $0 EDGAR
2013-03-28 Exer (M) +2,540 $711
Showing 3140 of 43
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.